Any supports for physician's overseas scientific conference attendance to prohibit

Many foreign multinational drug corporations and a part of domestic major companies have supported physicians who attended to the overseas seminars or scientific conferences as their marketing strategic project. However, this type of practices by any pharmaceutical company will be treated as an unfair trade act in the future.

The KPMA regarded the high rate of distribution margins raised by ...